Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray - Wikidata - wikimedia - TriplyDB

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

http://www.wikidata.org/entity/Q28204313

about

sameAs

ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature FOXP1 directly represses transcription of proapoptotic genes and cooperates with NF-κB to promote survival of human B cells Are we ready to stratify treatment for diffuse large B-cell lymphoma using molecular hallmarks?Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs Epigenetic down-regulation of the tumor suppressor gene PRDM1/Blimp-1 in diffuse large B cell lymphomas: a potential role of the microRNA let-7 Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomas Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers A novel diffuse large B-cell lymphoma-associated cancer testis antigen encoding a PAS domain protein A cytomorphological and immunohistochemical profile of aggressive B-cell lymphoma: high clinical impact of a cumulative immunohistochemical outcome predictor score Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma Modern classification of neoplasms: reconciling differences between morphologic and molecular approaches A 61-year-old man with dyspepsia and weight loss A new description of cellular quiescence miR-155 as a Biomarker in B-Cell Malignancies Primary Non-Hodgkin's Lymphoma of the Vulva: A Case Report and Literature Review The role of gender in patients with diffuse large B cell lymphoma treated with rituximab-containing regimens: a meta-analysis Next-generation prognostic assessment for diffuse large B-cell lymphoma How I treat HIV-associated lymphoma The genetic landscape of diffuse large B-cell lymphoma Treatment of diffuse large B cell lymphoma Beyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphoma Man's best friend: what can pet dogs teach us about non-Hodgkin's lymphoma?Interim fluorine-18 fluorodeoxyglucose PET-computed tomography and cell of origin by immunohistochemistry predicts progression-free and overall survival in diffuse large B-cell lymphoma patients in the rituximab era.Correlation of pretreatment 18F-FDG uptake with clinicopathological factors and prognosis in patients with newly diagnosed diffuse large B-cell lymphoma.Allogeneic Hematopoietic Cell Transplantation as Curative Therapy for Patients with Non-Hodgkin Lymphoma: Increasingly Successful Application to Older Patients Dysregulated MicroRNA Expression Profiles and Potential Cellular, Circulating and Polymorphic Biomarkers in Non-Hodgkin Lymphoma Assessment of bone marrow involvement in patients with lymphoma: report on a consensus meeting of the Korean Society of Hematology Lymphoma Working Party Recent insights in the pathogenesis of post-transplantation lymphoproliferative disorders Evolution of frontline treatment of diffuse large B-cell lymphoma: a brief review and recent update Approach to therapy of diffuse large B-cell lymphoma in the elderly: the International Society of Geriatric Oncology (SIOG) expert position commentary Specific expression of miR-17-5p and miR-127 in testicular and central nervous system diffuse large B-cell lymphoma Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab Diffuse large B-cell lymphoma: current strategies and future directions Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001 T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma EZH2 codon 641 mutations are common in BCL2-rearranged germinal center B cell lymphomas Common variants on 14q32 and 13q12 are associated with DLBCL susceptibility Mature aggressive B-cell lymphoma across age groups - molecular advances and therapeutic implications.

P2860

Q21198873-9B37AA0A-A71C-4116-A288-C65356DB3D8D Q24304887-397DF2EB-EA89-447A-9D19-6067ACA6E286 Q24597424-15B5DF54-CC86-4925-A04C-734DCEF4253D Q24618086-F22521B4-F472-4B36-BBD7-7514BAEF067A Q24624514-7A7D6BA3-7274-48DE-875D-C9AD11E28112 Q24643447-D2DDC6F6-271F-4A15-B101-650E3353CF6B Q24645617-3060266B-8265-4FD9-ACBE-40308C3F8B09 Q24646379-0D3D5EFF-B5E0-4D5D-89BC-34E37EEC53A0 Q24648046-C2DC566A-64E4-4080-A325-03869425829A Q24653343-61EF4E8E-708E-4E82-84BE-B971B6B71FD7 Q24676965-43774E96-EC8E-4921-A948-586E784B5E8A Q24813069-8CAB1756-E791-4C2E-8FEE-7AA445804FAB Q24813742-D466840A-D45E-4DA9-8525-320DE64F3EED Q25257330-D14B024B-B8F5-49F4-A577-C0DD54F93678 Q26746573-6B27C468-7F18-47A2-8A12-35BE928CC2F1 Q26766569-97FB1E30-E592-44E0-8B05-52BCAA38DBBB Q26795818-B1F36E20-4C04-450E-B147-32C64496AD05 Q26796428-DA14F8E5-5CB4-4F3C-9BCA-A7CDCB5DAE0F Q26821860-771C5026-487C-497C-94CC-A05E087E596F Q26866537-980ADCAB-6865-4D1F-A724-06F24CB3C25E Q27006062-84ADBD58-1966-43E9-B1DD-67D62BCB7959 Q27013785-3D3DAB42-D26E-4B64-9B44-B6C7185302F7 Q27027137-F05AD13C-2DA7-42C8-B130-515D20A75227 Q27314782-86E85344-F2D4-4C0F-A43C-9B5B50C4E18D Q27314809-D26DCA88-C936-44A3-B23B-E62279B5FF2B Q28066710-62BDB424-2E2E-4547-A176-293AB396DE46 Q28071905-B2F2CC17-6462-404E-AE31-0D68B80EA55C Q28073223-A3298416-D299-4591-B0F9-7119C5D6D4BF Q28075701-5E5ED308-3CDF-428F-8675-FABE59050367 Q28078869-A0157BCE-D244-4929-B6FC-FB50B00387EC Q28088365-7078EB1E-FA00-49CB-BB03-CDB43E1EE507 Q28238192-FFBBF64F-31EB-4F9D-96B6-5433E95E0D2E Q28253182-D67207E6-9F74-4F0E-8CF9-6CA0EF3A7E1B Q28256567-B66E5890-B145-461E-8F29-9DEA5C02F25B Q28269136-BEECD1DD-5447-4E67-9E4A-BE6E9ECC8E09 Q28271344-5068646D-C5DD-475F-8945-B4F16D77748D Q28306819-C3151967-BFBC-422D-8A76-0A49D1DBDB15 Q28741454-B25BA0BF-A4BB-4E08-A5EC-FD46BA201CD2 Q28943537-454302BC-8855-47E0-BA94-E083EEF52F25 Q30240133-F821C8AC-462D-4B46-9D3B-80E84AF8C940

P2860

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

http://www.wikidata.org/entity/Q28204313

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Confirmation of the molecular ...... stry using a tissue microarray

@ast

Confirmation of the molecular ...... stry using a tissue microarray

@en

Confirmation of the molecular ...... stry using a tissue microarray

@nl

type

label

Confirmation of the molecular ...... stry using a tissue microarray

@ast

Confirmation of the molecular ...... stry using a tissue microarray

@en

Confirmation of the molecular ...... stry using a tissue microarray

@nl

prefLabel

Confirmation of the molecular ...... stry using a tissue microarray

@ast

Confirmation of the molecular ...... stry using a tissue microarray

@en

Confirmation of the molecular ...... stry using a tissue microarray

@nl

P1433

Q28204313-709381A9-C6A8-44AD-9D9D-AB522D9F83FB

P1476

Q28204313-D28F1C57-D890-40B0-86D6-6A84C9A6C4C7

P2093

Q28204313-0543C8E8-CC14-4209-92C2-B04552667776

Q28204313-25B9CC32-80A0-4BD6-89A6-B75853E872A6

Q28204313-2D61DB72-E904-49BB-92A5-8776CF898D4A

Q28204313-57F592A7-A761-47D7-99FC-25BCE88D7C38

Q28204313-A2C79E3C-00BB-49A4-8FC9-9017DB8BF487

Q28204313-BD052660-993A-42B9-81E6-4C31E1394ED0

Q28204313-DF1885A0-3072-49F6-AF59-2497EADEC11B

P304

Q28204313-75FD9D42-FA3A-42D5-9924-4312141A42AC

P31

Q28204313-0166F93B-D1C1-4187-B68B-5A49A3187FE2

P3181

Q28204313-D49684F6-32B3-4731-8783-CF4D92883061

P356

Q28204313-AA81FBB5-FFDE-4E5B-98BA-FDA1349E7E8B

P407

Q28204313-16A654DC-A0FB-46AA-A29D-18FDA6091AC4

P433

Q28204313-3B10F27C-B08E-4EEE-8267-B524A33F5C04

P478

Q28204313-A08F8F85-E2AF-4CB8-8F82-1AC5C1C7D97A

P50

Q28204313-0AC32DCD-B394-4546-8F75-4EA0D5E9EB1D

Q28204313-2B56E76B-3F32-482C-9613-D408CCFEED7F

Q28204313-33563FFB-A2A5-4E66-A1AC-497E303B8689

Q28204313-4F11B052-F743-489D-96A0-F005F8A5748C

Q28204313-5BC3D622-2E49-4B0D-8501-73326469BD2F

Q28204313-65579FFD-6426-4B20-88DC-6922D22041B3

Q28204313-8D986440-3C20-4430-B789-D103098204CA

Q28204313-9EDDB62C-BA22-497B-A6D0-288F23C8C538

Q28204313-A3002E09-227A-48A4-9A08-EBE8047B31AA

Q28204313-AB22E89C-1F52-47CA-980A-5DBE820C0211

P577

Q28204313-DA02D92E-0B4B-4950-8253-A23A6FA8E1A2

P5875

Q28204313-2077C91A-A7CE-4B44-9856-37C9F7F017A6

P698

Q28204313-03B38E37-AD93-4EF2-9883-2469CEE2CE4C

P921

Q28204313-59F0F1D2-7438-4A9C-AAA5-65F7CF785A47

P3181

P356

BLOOD-2003-05-1545

P1433

P1476

Confirmation of the molecular ...... stry using a tissue microarray

@en

P2093

Christine P Hans

http://www.w3.org/2001/XMLSchema#string

Elaine S Jaffe

http://www.w3.org/2001/XMLSchema#string

H Konrad Müller-Hermelink

http://www.w3.org/2001/XMLSchema#string

Lynette M Smith

http://www.w3.org/2001/XMLSchema#string

Rita M Braziel

http://www.w3.org/2001/XMLSchema#string

Timothy C Greiner

http://www.w3.org/2001/XMLSchema#string

Zenggang Pan

http://www.w3.org/2001/XMLSchema#string

P304

275-82

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

289341

http://www.w3.org/2001/XMLSchema#string

P356

10.1182/BLOOD-2003-05-1545

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

Andreas Rosenwald

Alison H Banham

Joseph M Connors

Brunangelo Falini

Randy D Gascoyne

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

9085330

http://www.w3.org/2001/XMLSchema#string

P698

14504078

http://www.w3.org/2001/XMLSchema#string

P921

immunohistochemistry